Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Pharmaceutical Glass Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

globenewswire.com
GLW Corning Incorporated is mentioned as a key company in the pharmaceutical glass packaging market. The article discusses market growth and innovation in glass materials, which Corning is likely involved in, but provides no specific sentiment towards the company itself. OI Owens Illinois, Inc. is listed as a key player in the pharmaceutical glass packaging market. The article highlights the overall market's growth and the importance of glass packaging, but offers no specific sentiment or performance details for Owens Illinois.

Pharmaceutical Glass Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 Dublin, May 25, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Glass Packaging Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering.

The Global Pharmaceutical Glass Packaging Market was valued at USD 23.9 billion in 2025 and is estimated to grow at a CAGR of 10.3% to reach USD 63.1 billion by 2035.

The market is driven by the rising need for high-quality packaging that ensures product integrity and stability. Increasing demand for pharmaceutical products, supported by demographic shifts and growing long-term health conditions, is accelerating industry expansion. Glass remains a preferred material due to its superior chemical resistance and ability to maintain drug efficacy over time. Manufacturers are developing advanced packaging solutions that combine durability with improved performance. Continuous innovation in lightweight, break-resistant, and environmentally sustainable glass materials enhances safety standards while meeting regulatory expectations. These developments are strengthening the role of glass packaging as a critical component in pharmaceutical supply chains.

The market is also influenced by strict regulatory requirements focused on ensuring drug safety and preventing contamination. Global health authorities are enforcing standards that require packaging materials to maintain product stability under various conditions. This has encouraged a shift toward higher-grade materials, particularly those offering enhanced chemical resistance and thermal stability. As a result, manufacturers are adopting advanced glass compositions to meet compliance standards and improve packaging reliability.

In 2025, the Type I borosilicate glass segment held a 62.6% share due to its superior resistance to chemical interactions and its stability under varying temperatures. The demand for sensitive pharmaceutical formulations supports the adoption of this material. Regulatory requirements emphasizing high-performance packaging materials contribute to increased utilization of Type I borosilicate glass.

The tubular glass segment reached USD 11.2 billion in 2025, known for its precision, durability, and compatibility with advanced pharmaceutical applications. Its structural properties and resistance to chemical reactions make it suitable for critical packaging needs. Additionally, its compatibility with automated production systems increases its adoption, allowing greater efficiency and product quality in large-scale operations.

North America accounted for a 35.3% share of the Pharmaceutical Glass Packaging Market in 2025. The region focuses on quality standards, regulatory compliance, and sustainable manufacturing practices. Demand for advanced pharmaceutical packaging solutions encourages the adoption of high-purity glass materials and innovative coating technologies. Government initiatives promoting sustainable materials reinforce the shift toward advanced glass packaging.

Key companies in the market include Ardagh Group S.A., Beatson Clark Ltd., Bormioli Pharma S.p.A., Corning Incorporated, DWK Life Sciences GmbH, Gerresheimer AG, Hindustan National Glass & Industries Ltd., Nipro Corporation, Owens Illinois, Inc., Piramal Glass Limited, Schott AG, SGD Pharma (SGD S.A.), Shandong Pharmaceutical Glass Co., Ltd., Stevanato Group S.p.A., and Stolzle Glass Group. Companies strengthen their market position through innovation, collaborations, and capacity expansion.

They invest in research and development to create advanced glass formulations with improved chemical resistance and durability. Partnerships with pharmaceutical manufacturers enable better alignment with evolving packaging requirements. Companies expand production capabilities to meet rising global demand and ensure consistent supply. Sustainability initiatives, including lightweight and recyclable glass solutions, are becoming a key focus area.

Comprehensive Market Analysis and Forecast

Key Attributes:

Industry Insights

Company Profiles

Global Players:

Regional Players:

Local Players:

For more information about this report visit https://www.researchandmarkets.com/r/pd8isn

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment